Accretion Pharmaceuticals Ltd.
192.00-8.0 (-4.00%)
25 Aug, 1:59 PM
Income Statement
Abridged
Understanding Income Statement
Accretion Pharmaceuticals Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Accretion Pharmaceuticals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Accretion Pharmaceuticals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
Business Segment Analysis
FY End:
Mar 25
Accretion Pharmaceuticals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
Capex
Manifaturig and sale of Pharmaceutial products (100.0%)₹ 1.61 Cr
Revenue / Sales
Manifaturig and sale of Pharmaceutial products (100.0%)₹ 57.38 Cr
Assets
Manifaturig and sale of Pharmaceutial products (100.0%)₹ 39.87 Cr
Operating Income
Manifaturig and sale of Pharmaceutial products (100.0%)₹ 11.16 Cr
Regional Segment Analysis
FY End:
Mar 25
Accretion Pharmaceuticals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
Revenue / Sales
Domestic sales (84.7%)₹ 52.61 CrExport sales (7.7%)₹ 4.76 CrExport sales (7.7%)₹ 4.76 Cr
Historical Segment Analysis
Track how Accretion Pharmaceuticals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
Business
Frequently Asked Questions
What is the revenue of Accretion Pharmaceuticals Ltd.?
The latest trailing twelve month revenue of Accretion Pharmaceuticals Ltd. is ₹ 89.63 Cr, reflecting a 1-year growth of 56.21% and a 3-year CAGR of 45.02%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Accretion Pharmaceuticals Ltd.?
The latest trailing twelve month net profit (PAT) of Accretion Pharmaceuticals Ltd. is ₹ 9.67 Cr, with a 3-year earnings CAGR of 358.80%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Accretion Pharmaceuticals Ltd.?
The trailing twelve month EBITDA of Accretion Pharmaceuticals Ltd. is approximately ₹ 13.74 Cr (based on an operating margin of 15.33%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Accretion Pharmaceuticals Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Accretion Pharmaceuticals Ltd. is 9.03. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Accretion Pharmaceuticals Ltd.?
The debt-to-equity ratio of Accretion Pharmaceuticals Ltd. stands at 0.23. The interest coverage ratio is 16.21x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Accretion Pharmaceuticals Ltd.?
The estimated book value per share of Accretion Pharmaceuticals Ltd. is 47.25 (derived from a P/B ratio of 4.06 and market price of ₹ 192.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Accretion Pharmaceuticals Ltd.?
The trailing twelve month operating cash flow of Accretion Pharmaceuticals Ltd. is ₹ -15.47 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Accretion Pharmaceuticals Ltd. report consolidated or standalone financials?
Accretion Pharmaceuticals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.